Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1642 1646
This examiner grants 48% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 14701912 | RNA-Guided Human Genome Engineering | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 14681510 | RNA-Guided Human Genome Engineering | Final Rejection | President and Fellows of Harvard College |
| 14318933 | RNA-Guided Human Genome Engineering | Final Rejection | President and Fellows of Harvard College |
| 17625264 | Methods of Enhancing Immunogenicity of Cancers | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | Non-Final OA | Allogene Therapeutics, Inc. |
| 17625326 | TUMOR IMMUNOTHERAPY USING SINDBIS VIRAL VECTORS AND AGONIST MONOCLONAL ANTIBODIES | Final Rejection | New York University |
| 18255745 | METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18062937 | PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY | Final Rejection | The Board of Regents of The University of Texas System |
| 16643607 | Radioluminescent Nanoparticles for Radiation-Triggered Controlled Release Drugs | Final Rejection | PURDUE RESEARCH FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy